Role of lipidomics in the development of complications of pregnancy


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To carry out a systems analysis of the data available in the literature on lipid markers in the great obstetric syndromes. Materials and methods. The review includes the data of foreign and Russian articles published in the past 5 years and found in Pubmed and Scopus on studies of the great obstetric syndromes. Results. The paper gives the main markers of the lipid profile in the great obstetric syndromes. The determination of serum lipidomics in a pregnant woman is promising in this area. But most studies were limited by a small sample size and no assessments of lipidomic alterations with disease progression. Therefore, further investigations are needed in this area, including the assessment of changes in the lipid prof ile over time in order to develop an individual pregnancy management approach in these abnormalities. Conclusion. To improve outcomes for both the mother and the fetus, the new markers of the great obstetric syndromes are needed to be sought and introduced for their prediction and monitoring.

全文:

受限制的访问

作者简介

Olga Ivanova

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: lelia_tk@mail.ru
post-graduate of the maternity ward

Natalia Starodubtseva

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: n_starodubtseva@oparina4.ru
Candidate of Biological Sciences, Head of the Laboratory of Proteomics and Metabolomics of Human Reproduction

Roman Shmakov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: r_shmakov@oparina4.ru
MD, Ph.D., chief physician

参考

  1. Ghulmiyyah L., Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin. Perinatol. 2012; 36(1): 56-9.
  2. Di Renzo G.C. The great obstetrical syndromes. J. Matern. Fetal Neonatal Med. 2009; 22(8): 633-5.
  3. Brosens I., Pijnenborg R., Vercruysse L., Romero R. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 2011; 204(3): 193-201.
  4. Hinterwirth H., Stegemann C., Mayr M. Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease. Circ. Cardiovasc. Genet. 2014; 7(6): 941-54.
  5. Стародубцева Н.Л., Бугрова А.Е., Кононихин А. С., Вавина О.В., Широкова В.А., Наумов В.А., Гаранина И.А., Лагутин В.В., Попов И.А., Логинова Н.С., Ходжаева З.С., Франкевич В.Е., Николаев Е.Н., Сухих Г.Т. Возможность прогнозирования и ранней диагностики преэклампсии по пептидному профилю мочи. Акушерство и гинекология. 2015; 6: 46-52.
  6. Стародубцева Н.Л., Вавина О.В., Ходжаева З.С., Кононихин А.С., Попов И.А., Бугрова А.Е., Усманова З.И., Костюкевич Ю.И., Высоких М.Ю., Кан Н.Е., Николаев Е.Н., Сухих Г.Т. Создание методов сравнительного протеомного анализа мочи беременных и небеременных женщин для исследования процессов, протекающих при беременности. Акушерство и гинекология. 2014; 11: 41-8.
  7. Baardman M.E., Erwich J.J., Berger R.M., Hofstra R.M., Kerstjens-Frederikse W.S., Lütjohann D., Plosch T. The origin of fetal sterols in second-trimester amniotic fluid: endogenous synthesis or maternal-fetal transport. Am. J. Obstet. Gynecol. 2012; 207(3): 202. e19-25.
  8. Baardman M.E., Kerstjens-Frederikse W.S., Berger R.M., Bakker M.K., Hofstra R.M., Plosch T. The role of maternal-fetal cholesterol transport in early fetal life: current insights. Biol. Reprod. 2013; 88(1): 24-7.
  9. Palinski W. Maternal-fetal cholesterol transport in the placenta: good, bad, and target for modulation. Circ. Res. 2009; 104(5): 569-71.
  10. Wang Q., Würtz P., Auro K., Makinen V.P., Kangas A.J., Soininen P. et al. Metabolic profiling of pregnancy: crosssectional and longitudinal evidence. BMC Med. 2016; 14(1): 2-14.
  11. Farias D.R., Franco-Sena A.B., Vilela A., Lepsch J., Mendes R.H., Kac G. Lipid changes throughout pregnancy according to early pregnancy BMI: results from a prospective cohort. BJOG. 2016; 123(4): 570-8.
  12. Charlton F., Tooher J., Rye K.A., Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. 2014; 23(3): 203-12.
  13. Spracklen C.N., Smith C.J., Saftlas A.F., Robinson J.G., Ryckman K.K. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am. J. Epidemiol. 2014; 180(4): 346-58.
  14. Wang C., Zhu W., Wei Y., Su R., Feng H., Lin L. et al. The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J. Diabetes Res. 2016; 2016: 3013567.
  15. Ryckman K.K., Spracklen C.N., Smith C.J., Robinson J.G., Saftlas A.F. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015; 122(5): 643-51.
  16. Emet T., Ustüner I., Güven S.G., Balik G., Ural U.M., Tekin Y.B. et al. Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes. Arch. Gynecol. Obstet. 2013; 288(1): 49-55.
  17. Pecks U., Brieger M., Schiessl B., Bauerschlag D.O., Piroth D., Bruno B. et al. Maternal and fetal cord blood lipids in intrauterine growth restriction. J. Perinat. Med. 2012; 40(3): 287-96.
  18. Moayeri M., Heida K.Y., Franx A., Spiering W., de Laat M.W., Oudijk M.A. Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch. Gynecol. Obstet. 2017; 295(2): 313-23.
  19. Jiang S., Jiang J., Xu H., Wang S., Liu Z., Li M. et al. Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: a meta-analysis. Taiwan. J. Obstet. Gynecol. 2017; 56(1): 9-15.
  20. Mendola P., Ghassabian A., Mills J.L., Zhang C., Tsai M.Y., Liu A., Yeung E.H. Retinol-binding protein 4 and lipids prospectively measured during early to midpregnancy in relation to preeclampsia and preterm birth risk. Am. J. Hypertens. 2017; 30(6): 569-76.
  21. Shen H., Liu X., Chen Y., He B., Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open. 2016; 6(12): e013509.
  22. Korkes H.A., Sass N., Moron A.F., Câmara N.O., Bonetti T., Cerdeira A.S. et al. Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia. PLoS One. 2014; 9(10): e110747.
  23. Новгородцева Т.П., Караман Ю.К., Жукова Н.В., Лобанова Е.Г., Антонюк М.В. Роль нарушения липидного обмена в формировании метаболического синдрома. Здоровье. Медицинская экология. Наука. 2011; 44(1): 64-7.
  24. Hirschmugl B., Desoye G., Catalano P., Klymiuk I., Scharnagl H., Payr S. et al. Maternal obesity modulates intracellular lipid turnover in the human term placenta. Int. J. Obes. (London). 2017; 41(2): 317-23.
  25. Bao W., Dar S., Zhu Y., Wu J., Rawal S., Li S. et al. Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study. J. Diabetes. 2017; April 24. doi: 10.1111/1753-04 07.12563.
  26. Law K.P., Mao X., Han T.L., Zhang H. Unsaturated plasma phospholipids are consistently lower in the patients diagnosed with gestational diabetes mellitus throughout pregnancy: A longitudinal metabolomics study of Chinese pregnant women part 1. Clin. Chim. Acta. 2017; 465: 53-71.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2018
##common.cookie##